Compare ANIP & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | CCU |
|---|---|---|
| Founded | 2001 | 1850 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 1999 | 2001 |
| Metric | ANIP | CCU |
|---|---|---|
| Price | $71.99 | $11.92 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 5 | 2 |
| Target Price | ★ $110.00 | $12.00 |
| AVG Volume (30 Days) | ★ 397.3K | 123.8K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.90% |
| EPS Growth | ★ 419.23 | N/A |
| EPS | ★ 2.32 | N/A |
| Revenue | ★ $206,547,000.00 | N/A |
| Revenue This Year | $21.01 | $7.42 |
| Revenue Next Year | $17.59 | $4.71 |
| P/E Ratio | $31.49 | ★ $18.35 |
| Revenue Growth | ★ 2.47 | N/A |
| 52 Week Low | $70.15 | $10.71 |
| 52 Week High | $99.50 | $15.36 |
| Indicator | ANIP | CCU |
|---|---|---|
| Relative Strength Index (RSI) | 38.23 | 51.97 |
| Support Level | $70.15 | $11.41 |
| Resistance Level | $83.43 | $12.13 |
| Average True Range (ATR) | 1.97 | 0.37 |
| MACD | -0.20 | -0.06 |
| Stochastic Oscillator | 9.50 | 41.24 |
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.